BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6149573)

  • 1. Activation of C1.
    Colomb MG; Arlaud GJ; Villiers CL
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):283-92. PubMed ID: 6149573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional model of subcomponent C1 of human complement.
    Weiss V; Fauser C; Engel J
    J Mol Biol; 1986 Jun; 189(3):573-81. PubMed ID: 3023630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subunit interactions in the first component of complement, C1.
    Lakatos S
    Biochem Biophys Res Commun; 1987 Dec; 149(2):378-84. PubMed ID: 2827640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first component of human complement (C1): activation and control.
    Ziccardi RJ
    Springer Semin Immunopathol; 1983; 6(2-3):213-30. PubMed ID: 6314572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Models for C1. Tools or toys? The real biological challenge.
    Colomb MG; Arlaud GJ; Chesne S
    Behring Inst Mitt; 1989 Jul; (84):121-8. PubMed ID: 2552979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-operative interaction of subcomponents of the first component of complement with IgG: a functional defect of dimeric Facb from rabbit IgG.
    Okada M; Udaka K; Utsumi S
    Mol Immunol; 1985 Dec; 22(12):1399-406. PubMed ID: 3007976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cells.
    Reboul A; Bensa JC; Colomb MG
    Biochem J; 1986 Jan; 233(2):559-64. PubMed ID: 3006672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular mechanism for the activation of the first component of complement by immune complexes.
    Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
    Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of macromolecular interactions between complement subcomponents C1q, C1r, C1s, and immunoglobulin IgM by sedimentation analysis using the analytical ultracentrifuge.
    Poon PH; Schumaker VN
    J Biol Chem; 1991 Mar; 266(9):5723-7. PubMed ID: 2005109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron microscopy of the first component of human complement.
    Schumaker VN; Strang CJ; Siegel RL; Phillips ML; Poon PH
    Surv Immunol Res; 1982; 1(4):305-15. PubMed ID: 6314471
    [No Abstract]   [Full Text] [Related]  

  • 16. Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1s, C1r2-C1s2 and C1.
    Thielens NM; Villiers MB; Reboul A; Villiers CL; Colomb MG
    FEBS Lett; 1982 May; 141(1):19-24. PubMed ID: 6282646
    [No Abstract]   [Full Text] [Related]  

  • 17. Models for the C1 complex determined by physical techniques.
    Perkins SJ
    Behring Inst Mitt; 1989 Jul; (84):129-41. PubMed ID: 2552980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the fluid-phase proteolytic cleavage of human complement subcomponents C4 and C2 by C1s and C1r2-C1s2.
    Thielens NM; Villiers CL; Villiers MB; Colomb MG
    FEBS Lett; 1984 Jan; 165(1):111-6. PubMed ID: 6319179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of immune complexes in the activation of the first component of human complement.
    Ziccardi RJ
    J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.